u/spain_receta

That shortage notice was national and does not apply where the question is coming from.

Lyophilisation removes the water that drives most degradation pathways. That is why the dry cake is comparatively robust and the reconstituted solution is not.

How many days in transit, and which month?

Have you read the published reimbursement criteria where you are?

Pharmacy link removed. No links of any kind here, in any country, for any reason.

What does the local patient information leaflet say?

The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.

The arithmetic in full: concentration is mass over volume, so 30mg into 2mL gives 15mg/mL. A U-100 syringe is graduated at 100 units per millilitre, so 1.5mg is 1.5 divided by 15 millilitres, which is 10 units.

hold the dose that works, the ladder is not a leaderboard

It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.

How many days in transit, and which month?

That is an authorisation question and you have answered a reimbursement one. They are decided by different bodies.

Pointing this one at a pharmacist locally. Eligibility questions have national answers we cannot give.

Are you comparing yourself with the trial mean or with the people who post the most?

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme.

Saving this one. It is the clearest statement of the stall problem I have read here.

bacteriostatic water has the preservative, sterile water does not

the trials titrated on a calendar, real people titrate on symptoms

Asked in my own language at a local pharmacy and got a clearer answer in five minutes than a fortnight of forum reading.

Not convinced. A warm pack on day six is expected behaviour from a pack designed for four.

It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.

Pointing this one at a pharmacist locally. Eligibility questions have national answers we cannot give.

Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.

I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your nausea pattern is a guess.

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

I keep a laminated card in the drawer with the arithmetic on it. Looks ridiculous. Has never once let me draw the wrong volume.

Careful. "The cold chain failed" is a strong claim and the evidence you have is a warm box.

dual agonist, so the GIP arm is doing something the sema threads will not tell you about

Regional stock changes the question rather than answering it: shorter lanes mean less exposure and fewer variables, which is why the warehouse question is worth asking before ordering in summer.

Correction: that stability figure covers the lyophilised powder, not the reconstituted solution. Different claim entirely.

Small fix — those two prices are for different pack sizes, which accounts for most of the gap.

a shortage in one member state is not a shortage in all of them

Yes, and the dead-space point is worth repeating: it is small, it is real, and it is the same for every draw.

The whole calculation, once, with real numbers.

You have a 5mg vial. You add 1mL of bacteriostatic water. Concentration is mass over volume: 5mg/mL. A U-100 insulin syringe is graduated at 100 units per millilitre, so one unit is 0.01mL.

To draw 5mg you need 5 divided by 5 millilitres, which is 100 units on the barrel. Write "5mg/mL" on the vial in marker before you put it away, and you never have to do this again for that vial.

That is sterile water, not bacteriostatic. Same appearance, different product, and it matters for a multi-draw vial.

The arithmetic in full: concentration is mass over volume, so 10mg into 3mL gives 3.33mg/mL.

Right, and the arithmetic behind it: 5mg in 2mL is 2.5mg/mL, so 0.25mg is 10 units.

Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them.

pens and vials are the same molecule, the price is the difference

Did the maths give you a whole number of units, or a fraction?

Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.

5mg into 3mL is 1.67mg/mL, and 1.5mg of that is 90 units